Abstract
As Mohs micrographic surgery (MMS) is more widely utilized for melanoma in situ (MIS) and lentigo maligna (LM), there is increasing concern over whether the procedure can negatively affect the treatment of upstaged tumors. Previous studies have shown that about 1–2% of MIS/LM treated with MMS require sentinel lymph node biopsy, but little is still known regarding surgical outcomes. We performed a retrospective chart review of 117 MIS/LM lesions treated with MMS at Brigham and Women’s Hospital. We found a low rate of tumor upstaging (8.5% or 10/117), and only 1.7% (2/117) required wide local excision and sentinel lymph node biopsy. In both patients, there was successful location of the sentinel nodes by surgical oncologists. This study highlights the low risk of MIS/LM upstaging, with the majority changing to T1a, and the low need for further surgical management after MMS. Collaboration with other surgical specialties ensures appropriate management of patients with upstaged tumors.
References
Nosrati A, Berliner JG, Goel S et al (2017) Outcomes of Melanoma in situ treated with Mohs micrographic surgery compared with wide local excision. JAMA Dermatol 153(5):436–441
Kunishige JH, Doan L, Brodland DG, Zitelli JA (2019) Comparison of surgical margins for lentigo maligna versus melanoma in situ. J Am Acad Dermatol. 81:204–212
Iorizzo LJ 3rd, Chocron I, Lumbang W, Stasko T (2013) Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ. Dermatol Surg 39(3 Pt 1):365–371
Etzkorn JR, Sobanko JF, Elenitsas R et al (2015) Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment. J Am Acad Dermatol 72(5):840–850
Funding
Dr. Waldman is supported by a career development award from the Dermatology Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
IRB approval status
Approved by the Partners Human Research Office.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Levoska, M.A., Schmults, C.D. & Waldman, A.H. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management. Arch Dermatol Res 312, 753–756 (2020). https://doi.org/10.1007/s00403-020-02034-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-020-02034-9